Stéphane Bancel

Stéphane Bancel (1972/1973) is a French businessman and the CEO and 9% owner of Moderna, an American biotechnology company.

Stéphane Bancel
Born1972/1973 (age 47–48)[1]
France
NationalityFrench
EducationÉcole Centrale Paris
University of Minnesota
Harvard Business School
OccupationBusinessman
Known forCEO and 9% owner of Moderna
Net worthUS$1.0 billion (April 2020)[1]
Title2013–

Early life

Bancel was born in France and earned his master's degrees in engineering from École Centrale Paris, and the University of Minnesota.[1] He went on to earn an MBA from Harvard Business School.[2]

Career

Bancel was a sales director at Eli Lilly, eventually becoming head of operations for Belgium.[2] In 2007, he became CEO of French diagnostics company BioMérieux.[2]

In 2011, Bancel joined Moderna, becoming CEO.[1] In 2016, Stat news, reported that Bancel led a highly secretive culture with little outside review of its science or research.[2]

Personal life

In April 2020, with the Moderna share price rising on news of imminent phase 2 human trials for its potential COVID-19 vaccine, Bancel's stake of about 9% became worth over $1 billion.[1]

References
  1. Tognini, Giacomo (3 April 2020). "Moderna CEO Stéphane Bancel Becomes A Billionaire As Stock Jumps On Coronavirus Vaccine News". Forbes. Retrieved 4 April 2020.
  2. Garade, Damien (13 September 2016). "Ego, ambition, and turmoil: Inside one of biotech's most secretive startups". Stat. Retrieved 18 May 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.